PharmaCielo Ltd.
PCLOF
$0.06
$0.008.72%
OTC PK
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 129.04% | -7.01% | 44.62% | -2.99% | 61.80% |
| Total Depreciation and Amortization | 408.58% | 326.21% | 12.67% | -108.20% | -73.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.92% | -7.11% | -46.95% | 13.65% | -75.46% |
| Change in Net Operating Assets | 84.26% | -262.22% | 303.77% | 97.11% | 9.69% |
| Cash from Operations | 114.86% | -267.55% | 66.11% | 8.37% | 71.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -110.05% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -30.84% |
| Cash from Investing | -110.05% | -- | -- | -- | -24.13% |
| Total Debt Issued | 500.00% | -80.00% | -14.66% | -100.00% | -82.64% |
| Total Debt Repaid | 102.78% | -60.53% | -192.23% | 82.33% | 81.98% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 106.83% | -69.43% | -42.37% | 14.52% | -66.42% |
| Foreign Exchange rate Adjustments | -76.24% | 773.33% | -350.00% | 84.85% | -68.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.11% | 627.62% | 934.29% | 89.55% | 205.73% |